icon-    folder.gif   Conference Reports for NATAP  
 
  Back grey_arrow_rt.gif
 
 
 
 
 
ANALYSIS OF PROTOCOL DEFINED VIROLOGIC FAILURE THROUGH WEEK 48 FROM A PHASE 2 TRIAL (P011) OF ISLATRAVIR AND DORAVIRINE IN TREATMENT-NAÏVE ADULTS WITH HIV-1 INFECTION
 
 
  Presented at the 23rdInternational AIDS Conference
Reported by Jules Levin
https://go.aws/2yKrAwK
 
July 06-10, 2020
 
C. Orkin1, J.-M. Molina2, Y. Yazdanpanah3, C. Chahin Anania4, E. DeJesus5, J. Eron6, S.O. Klopfer7, A Grandhi7, K. Eves7, D. Jackson Rudd7, M.N Robertson7, P. Sklar7, C. Hwang7, G.J. Hanna7, T. Correll7
1Queen Mary University of London, London, United Kingdom, 2St-Louis Hospital and University, Department of Infectious Disease, Paris, France, 3Bichat Hospital, Paris, France, 4Hospital HernánHenríquezAravenaof Temuco, Temuco, Chile, 5Orlando Immunology Center, Orlando, United States, 6Division of Infectious Disease, University of North Carolina, Chapel Hill, North Carolina, United States, 7Merck & Co., Inc., Kenilworth, NJ, United States 


0706201

0706202

0706203

0706204

0706205

0706206

0706207

0706208